Live feed
·
INSIDERFilingvia Quantisnow
Janux Therapeutics Inc. logo

New insider Diraimondo Thomas claimed ownership of 101,532 shares (SEC Form 3)

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight
Quantisnow market dataNASDAQ
Janux Therapeutics Inc. logo
JANX
Janux Therapeutics Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2021
Get push alerts for JANX

Follow JANX and get a push notification the moment its next story breaks.

Full JANX profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track JANX (Janux Therapeutics Inc.) and more on Quantisnow.